Incannex Healthcare Inc. (IXHL) stock
IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.74−0.19 (-9.84%)
Close on Nov 17, 2026Market cap $21.83MP/E –Yield –
Incannex Healthcare operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Incannex Healthcare's operating cash flow for the twelve months ending Sep 30, 2026 was -$3.18M. For fiscal 2026 it was -$12.87M. The highest annual figure on record is -$3.91M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$12.87M | – |
| FY2025 | Jun 30, 2025 | -$12.51M | – |
| FY2024 | Jun 30, 2024 | -$15.85M | – |
| FY2023 | Jun 30, 2023 | -$10.75M | – |
| FY2022 | Jun 30, 2022 | -$12.81M | – |
| FY2021 | Jun 30, 2021 | -$6.91M | – |
| FY2020 | Jun 30, 2020 | -$3.91M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $521.00K | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.37M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$2.46M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$4.62M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$9.16M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$1.48M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$3.16M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$5.63M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$2.25M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$3.64M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$4.35M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$2.10M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$5.75M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$2.58M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$2.73M | – |
See a number that looks wrong?